Oncology Institute (NYSE: TOI) — Perfil da empresa, notícias e dados financeiros
Oncology Institute delivers comprehensive cancer care through personalized treatment plans and community-based clinical trials.
Oncology Institute
Oncology Institute (NASDAQ:TOI) focuses on delivering comprehensive cancer care through an integrated network. The company aims to provide patients with personalized treatment plans, leveraging cutting-edge research and technology to improve outcomes. Oncology Institute's projects span across various aspects of cancer treatment, including innovative therapy development, community-based clinical trials, and advancing precision medicine. The objective is to make high-quality oncology care accessible and affordable, ensuring a supportive environment for patients and their families. By continuously expanding its services and facilities, Oncology Institute strives to meet the growing needs of the communities it serves, promising a future where cancer treatment is more effective and compassionate.
Resumo
Operações
Produtos e/ou serviços de Oncology Institute
- Comprehensive cancer care services, offering personalized treatment plans including chemotherapy, radiation therapy, and surgical options.
- Cancer research programs, focusing on developing innovative treatments and understanding cancer biology.
- Supportive care services, providing emotional, nutritional, and rehabilitation support for patients and their families.
- Educational resources and events, aimed at increasing awareness about cancer prevention, early detection, and treatment options.
- Advanced diagnostic services, using cutting-edge technology for accurate cancer diagnosis and staging.
- Collaboration with pharmaceutical companies to develop and test new cancer drugs, enhancing treatment options available to patients.
equipe executiva do Oncology Institute
- Dr. Daniel Virnich FACHE, M.B.A., M.D.CEO & Executive Director
- Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.Chief Medical Officer
- Mr. Robert CarterChief Financial Officer
- Mr. Austin LeeVP of Accounting & Controller
- Mr. Rakesh PandaChief Information Officer
- Ms. Kristin EnglandChief Administrative Officer
- Mr. Mark Hueppelsheuser Esq.General Counsel
- Mr. Nolan MarianoChief People Officer
- Mr. Jordan McInerneyChief Development Officer
- Mr. Stephen CellaSenior Vice President of Finance
Principais indicadores financeiros
Resultados divulgados pela Oncology Institute, em USD.
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 502,7 mi | -36,1 mi | -60,6 mi | |
| 393,4 mi | -60,1 mi | -64,7 mi | |
| 324,2 mi | -77 mi | -83,1 mi | |
| 252,5 mi | -82 mi | 152 mil |